0001465826-14-000003.txt : 20140310
0001465826-14-000003.hdr.sgml : 20140310
20140310205943
ACCESSION NUMBER: 0001465826-14-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140306
FILED AS OF DATE: 20140310
DATE AS OF CHANGE: 20140310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/
CENTRAL INDEX KEY: 0001053369
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223542636
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
BUSINESS PHONE: 2017502646
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
FORMER COMPANY:
FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/
DATE OF NAME CHANGE: 19980121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NIGALAYE ASHOK G
CENTRAL INDEX KEY: 0001465825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15697
FILM NUMBER: 14682589
MAIL ADDRESS:
STREET 1: C/O EPIC PHARMA, LLC
STREET 2: 227-15 NORTH CONDUIT AVENUE
CITY: LAURELTON
STATE: NY
ZIP: 11413
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-03-06
0
0001053369
ELITE PHARMACEUTICALS INC /NV/
ELTP
0001465825
NIGALAYE ASHOK G
C/O EPIC PHARMA, LLC
227-15 NORTH CONDUIT AVENUE
LAURELTON
NY
11413
1
1
1
0
Chief Scientific Officer
Common Stock
2014-03-06
4
S
0
773050
0.8956
D
20688015
I
By Epic Investments, LLC
Common Stock
2014-03-07
4
S
0
1051450
0.68
D
20372580
I
By Epic Investments, LLC
Common Stock
14275289
D
Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Investments, LLC ("EI") and Epic Pharma, LLC ("EP"), which is a 10% owner of the issuer, and also serves as a director of the issuer.
Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
Ashok Nigalaye
2014-03-10